Posts in category Healthcare


Genocea Biosciences Inc (GNCA) Investors Run for the Hills; Here’s Why

Genocea shares are plunging on termination of genital herpes treatment GEN-003.

Read more

Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Announces Relaunch of Generic Depo-Provera in the US

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the reintroduction of the generic equivalent to Depo-Provera┬«1 …

Read more

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety …

Read more

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) and HLS Therapeutics Announce Agreement to Commercialize Vascepa in Canada

Amarin Corporation plc (ADR) (NASDAQ:AMRN) and HLS Therapeutics Inc. (“HLS”), announced today an exclusive agreement …

Read more

Gilead Sciences, Inc. (GILD) Obtains CFDA Approval for Sovaldi for Treatment of Chronic Hepatitis C Virus Infection

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the China Food and Drug Administration (CFDA) has approved …

Read more

Intercept Pharmaceuticals Inc (ICPT) Comments on Ocaliva Safety and Dosing

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) provided comment on the Ocaliva (obeticholic acid or OCA) Dear Healthcare …

Read more

Ascendis Pharma A/S (ASND) Shares Jump on the Back of Competitor’s Clinical Setback

Investors are snapping up Ascendis Pharma A/S (NASDAQ:ASND) shares following the news that competitor somavaratan …

Read more

Here’s Why Versartis Inc (VSAR) Shares Crashed Today

Friday turned out to be a nightmare for Versartis Inc (NASDAQ:VSAR) investors, after the drug …

Read more

Company Update (NASDAQ:JUNO): Juno Therapeutics Inc Opens New Headquarters and Research Center

Juno Therapeutics Inc (NASDAQ:JUNO) unveiled its new headquarters and research facility, located in the heart …

Read more

Intercept Pharmaceuticals Inc (ICPT) Investors Run for the Hills; Here’s Why

Shares of drug maker Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are in a freefall today. Why? An …

Read more